首页 | 本学科首页   官方微博 | 高级检索  
     

舒利迭配伍孟鲁斯特治疗中重度慢性阻塞性肺病疗效观察
引用本文:王鹏升. 舒利迭配伍孟鲁斯特治疗中重度慢性阻塞性肺病疗效观察[J]. 海南医学院学报, 2012, 18(2): 182-183,186
作者姓名:王鹏升
作者单位:河北沧州市中心医院老年内科,河北沧州,061001
基金项目:中国高校医学期刊临床专项资金项目
摘    要:目的:探究吸入舒利迭联合孟鲁斯特治疗慢性阻塞性肺病的效果。方法:本文收集2010年10月~2011年10月期间在我院就诊的100例慢性阻塞性肺病患者,将其随机分为观察组和对照组,每组各50例,观察组给予吸入舒利迭联合孟鲁斯特,对照组给予口服沐舒坦联合缓释茶碱,进行治疗前后临床疗效和肺功能判定。结果:观察组临床症状及肺功能明显改善。结论:糖皮质激素联合长效β2受体激动剂治疗慢性阻塞性肺病效果显著。

关 键 词:舒利迭  孟鲁司特  中重度慢性阻塞性肺病

Effect of Seretide and Montelukast on severe chronic obstructive pulmonary disease
WANG Peng-sheng. Effect of Seretide and Montelukast on severe chronic obstructive pulmonary disease[J]. Journal of Hainan Medical College, 2012, 18(2): 182-183,186
Authors:WANG Peng-sheng
Affiliation:WANG Peng-sheng (Department of Senile Internal Medicine,Center Hospital of Cangzhou,Cangzhou 061001,China)
Abstract:Objective: to explore effect of Seretide and Montelukast on severe chronic obstructive pulmonary disease.Methods:A total of 100 cases with chronic obstructive pulmonary disease admitted from October 2010 to October 2011 in our hospital were selected,and randomly divided into treatment group and control group by half.Patients in treatment group were treated by inhalation therapy of Seretide and Montelukast,while patients in control group by oral Mucosolvan and sustained-release theophyline.Clinical efficacy and pulmonary function was evaluated before and after treatment.Results:Clinical symptoms and pulmonary function were significantly improved in the treatment group.Conclusions:Inhalation of glucocorticoid and long acting β agonists is effective in treating chronic obstructive pulmonary disease.
Keywords:Seretide  Montelukast  Moderate and severe chronic obstructive pulmonary disease
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号